Deutsche Bank’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Deutsche Bank’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-105,715	Closed	-$3.63M	–	6492
2014 Q4	$3.63M	Sell	105,715 -56,626	-35%	-$1.85M	﹤0.01%	2217
2014 Q3	$4.84M	Buy	162,341 +29,149	+22%	+$618K	﹤0.01%	1860
2014 Q2	$2.67M	Sell	133,192 -155,186	-54%	-$3.56M	﹤0.01%	2260
2014 Q1	$7.84M	Buy	288,378 +30,980	+12%	+$822K	0.01%	1502
2013 Q4	$5.33M	Sell	257,398 -64,681	-20%	-$1.22M	﹤0.01%	1724
2013 Q3	$5.86M	Sell	322,079 -414,144	-56%	-$7.48M	﹤0.01%	1706
2013 Q2	$12.2M	Buy	+736,223	New	+$11.8M	0.01%	1121

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Deutsche Bank's AUXL Position: Q1 2015 in Review

Deutsche Bank sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 105,715 shares — an estimated $3.63M sold.

Deutsche Bank first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $12.2M in Q2 2013. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Deutsche Bank reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 105,715 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $3.63M.
Deutsche Bank first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Deutsche Bank's AUXILIUM PHARAMCEUTICALS INC position peaked at $12.2M in Q2 2013.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.